Access to Investigational Drugs Outside a Clinical Study
Kura Oncology is committed to realizing the promise of precision medicines for the treatment of cancer. To do this, we conduct clinical studies to assess the safety and efficacy of investigational drugs, and the data generated from these studies allows us to obtain the necessary approvals from Health Authorities which allow for broad access to medicines.
At Kura Oncology, we believe that wherever possible, use of an investigational drug for a patient as part of a clinical study is preferable as clinical studies can generate data that may lead to the approval of drugs and, consequently, to wider patient availability.